Elsevier Boosts Global COVID-19 Research with Neo4j

Elsevier, a Dutch publishing company, is utilizing Neo4j graph technology to analyze its vast network of scientific content related to COVID-19. The project, Core Citation Graph (C-Graph), aims to query the network and provide insights into drug repurposing for COVID-19 treatment. By applying graph technology, Elsevier was able to build a polypharmacology model, predict effective drug combinations, and identify key proteins related to coronaviruses such as SARS-CoV-1 and MERS-CoV. The Neo4j platform enabled the team to collect and analyze data efficiently, producing simplified graphs that helped researchers understand COVID-19 mechanistic pathways in a matter of weeks. This technology is expected to be used beyond COVID-19 research, supporting studies into immunological diseases and enabling more targeted insights for researchers.

Use this post, company, and trend context to find content marketing opportunities, perform competitive analysis, or address product feature gaps via the Plushcap MCP server or the Plushcap API.